Author:
Lv Chen-Xi,Zhou Lin-Po,Yang Ye-Bing,Shi Jing,Dong Fan-He,Wei Hao-Ran,Shan Yu-Qiang
Abstract
Abstract
Background
Innate/adaptive immunity is the key to anti-tumor therapy. However, its causal relationship to Gastrointestinal (GI) cancer remains unclear.
Methods
Immunity genes were extracted from the MSigDB database. The Genome-wide association studies (GWAS) summary data of GI cancer were integrated with expression quantitative trait loci (eQTL) and DNA methylation quantitative trait loci (mQTL) associated with genes. Summary-data-based Mendelian randomization (SMR) and co-localization analysis were used to reveal causal relationships between genes and GI cancer. Two-sample MR analysis was used for sensitivity analysis. Single cell analysis clarified the enrichment of genes.
Results
Three-step SMR analysis showed that a putative mechanism, cg17294865 CpG site regulating HLA-DRA expression was negatively associated with gastric cancer risk. HLA-DRA was significantly differentially expressed in monocyte/macrophage and myeloid cells in gastric cancer.
Conclusion
This study provides evidence that upregulating the expression level of HLA-DRA can reduce the risk of gastric cancer.
Funder
the Key Project of Health Science and Technology plan of Hangzhou
Natural Science Foundation of Zhejiang Province
Publisher
Springer Science and Business Media LLC